about
Immunological aspects of chronic venous disease pathogenesisTRAIL-induced apoptosis and expression of death receptor TRAIL-R1 and TRAIL-R2 in bladder cancer cells.Novel Structurally Related Flavones Augment Cell Death Induced by rhsTRAILChalcones enhance TRAIL-induced apoptosis in prostate cancer cells.Effect of ALA-mediated photodynamic therapy in combination with tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) on bladder cancer cellsALA-induced photodynamic effect on vitality, apoptosis, and secretion of vascular endothelial growth factor (VEGF) by colon cancer cells in normoxic environment in vitro.Circulating concentration of markers of angiogenic activity in patients with sarcoidosis and idiopathic pulmonary fibrosis.The influence of ALA-mediated photodynamic therapy on secretion of selected growth factors by colon cancer cells in hypoxia-like environment in vitro.ALA-induced photodynamic effect on viability, apoptosis and secretion of S100 protein, secreted by colon cancer cells in vitro.The effect of ALA-PDT under normoxia and cobalt chloride (CoCl2)-induced hypoxia on adhesion molecules (ICAM-1, VCAM-1) secretion by colorectal cancer cells.ALA-mediated photodynamic effect on apoptosis induction and secretion of macrophage migration inhibitory factor (MIF) and of monocyte chemotactic protein (MCP-1) by colon cancer cells in normoxia and in hypoxia-like conditions in vitro.The role of selected flavonols in tumor necrosis factor-related apoptosis-inducing ligand receptor-1 (TRAIL-R1) expression on activated RAW 264.7 macrophages.Chrysin, apigenin and acacetin inhibit tumor necrosis factor-related apoptosis-inducing ligand receptor-1 (TRAIL-R1) on activated RAW264.7 macrophages.Targeting death receptor TRAIL-R2 by chalcones for TRAIL-induced apoptosis in cancer cells.Synthetic flavanones augment the anticancer effect of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL).Inhibition of inflammatory mediators by neobavaisoflavone in activated RAW264.7 macrophages.Enhanced TRAIL-mediated apoptosis in prostate cancer cells by the bioactive compounds neobavaisoflavone and psoralidin isolated from Psoralea corylifolia.Cytokines related to three major types of cell-mediated immunity in short- and long-term exposures to lead compounds.Chalcones and dihydrochalcones augment TRAIL-mediated apoptosis in prostate cancer cells.Chemical Composition and Anti-Inflammatory Effect of Ethanolic Extract of Brazilian Green Propolis on Activated J774A.1 Macrophages.Propolis: properties, application, and its potential.Ethanolic Extract of Polish Propolis: Chemical Composition and TRAIL-R2 Death Receptor Targeting Apoptotic Activity against Prostate Cancer CellsThe combination of TRAIL and isoflavones enhances apoptosis in cancer cells.Increase in activity of neutrophils and proinflammatory mediators in rats following acute and prolonged focal cerebral ischemia and reperfusion.Effect of flavone derivatives on interleukin-1beta (IL-1beta) mRNA expression and IL-1beta protein synthesis in stimulated RAW 264.7 macrophages.Structure-activity relationship in the ability of flavonols to inhibit chemiluminescence.Novel Triazole Hybrids of Betulin: Synthesis and Biological Activity Profile.The Influence of Toothpaste Containing Australian Melaleuca alternifolia Oil and Ethanolic Extract of Polish Propolis on Oral Hygiene and Microbiome in Patients Requiring Conservative Procedures.Interleukin-1β increases release of endothelin-1 and tumor necrosis factor as well as reactive oxygen species by peripheral leukocytes during experimental subarachnoid hemorrhage.Secretion of the angiogenic factor VEGF after photodynamic therapy with ALA under hypoxia-like conditions in colon cancer cells.Blood morphology and the levels of selected cytokines related to hematopoiesis in occupational short-term exposure to lead.Influence of iron on sperm motility and selected oxidative stress parameters in fertile males - a pilot study.Influence of ALA-mediated photodynamic therapy on secretion of interleukins 6, 8 and 10 by colon cancer cells in vitro.[Tumour-stroma interactions in urothelial cancer].Cytokines Produced by Lymphocytes in the Incompetent Great Saphenous Vein.The role of alert pathogens in bacterial diseases in patients hospitalized at the Department of Pulmonary Diseases and Tuberculosis Public Clinical Hospital No 3 in Zabrze in 2008-2012Chemokines and Growth Factors Produced by Lymphocytes in the Incompetent Great Saphenous VeinInhibition of neutrophils' chemiluminescence by ethanol extract of propolis (EEP) and its phenolic componentsImmunological parameters in patients suffering from alcohol-dependence syndromeDecreased human milk concentration of epidermal growth factor after preterm delivery of intrauterine growth-restricted newborns
P50
Q27011508-0EC81623-FD9C-4890-86D0-12E535C1D43AQ33568317-BC3EE67A-C1DF-4B29-81C3-9A12396F4929Q33838733-71BFF6B9-9B8D-452D-B48B-59B62842077AQ34616831-9FC283AD-2F51-47D5-9874-F3F00D5BFF29Q35104391-1CA05A18-5200-467A-A9AD-9931BCBE58FBQ35774989-D34B944B-FAE2-4ED9-BF07-6DD83AF7B820Q35800025-190D0445-3DDE-4DC8-8CC1-48BAD6C78212Q35836786-1721C742-09EA-4B4D-AA71-EC7735D11573Q36089042-9813CEC9-EE10-43F4-9B22-CFAA06C14A32Q36369638-D14ABEE2-37AE-4FBD-89A5-6AD611B00434Q38919442-3A3197D0-A293-4584-A3A3-187512C882BBQ38920840-34A2049F-564B-49B0-BC51-4467EDDB52B0Q38979660-22C31DAB-C93C-4EFD-96CD-22AF3079C98BQ39234178-89A7D853-4A93-4F9B-9A5D-C59E0F15B2F5Q39268110-74CFAC06-182E-4218-BD44-2D8ECB3900C0Q39548575-FFCF31BE-A2AC-47E7-AA99-88508F0CF49AQ39569765-A782F329-89DD-49DA-9A89-95DC8A3F5D91Q39620824-85DFE791-6D14-45F2-B256-23E503E92A97Q39666844-FC1FB63D-9115-4241-9A3A-C21D66AEE525Q41815031-A1EB062F-3C79-4C85-A5E3-03478E73C819Q42571791-0A5E71FF-483A-48F0-A2F2-DAE1C3E061F8Q42857689-907F752A-DD7B-415A-98A0-CC4C1F4E7009Q43119428-3C5BC788-C348-4FD5-8038-76A8B79E0ED7Q43265286-A7023AAD-3BC2-4436-9BEE-E9654824C7B2Q44316837-EE39E515-2606-43DB-868F-9BED9E1CEE2BQ46808887-62DC841D-5517-4B15-968A-1AB3AC34D04EQ47590254-689FD0BD-741F-4FEB-9C4B-72DCD58D10FDQ48305588-FE13926D-008F-4C76-B485-F7CB8A974B24Q48496920-FA61C097-05E7-456B-9E78-C678183958F0Q50100042-99E4AE8B-3DB2-4FB1-98E9-C771BD056E61Q51704321-945572AF-9B4C-4311-AA93-9D41EDAE323CQ51706052-97637DE7-60EB-46FF-9E40-8AD993BF6005Q52728522-C366944F-B43A-426E-987D-64C8902521D6Q53536050-8FB004E0-B5BB-4F8C-8F0D-52B2A89D72D9Q55664876-D733F173-591E-4D72-B8A9-DC16D10AF09DQ58583246-405BE93C-FD0A-4D3B-84BB-BA20E5BDB755Q61798086-2CE16F37-885E-41B2-8FA5-A1B864CC5B5EQ73273628-A70CE90D-F0B8-43A7-B218-4BEF381D5A3FQ73426147-72E4144B-B172-4B0C-BBBD-2BCD26E29FB3Q80110854-898B6520-1275-49AD-B11C-847A25DF07B3
P50
description
Polish researcher
@en
Pools onderzoeker
@nl
cercetător polonez
@ro
chercheur polonais
@fr
investigador polaco
@gl
investigador polonès
@ca
investigador
@es
polnischer Forscher
@de
polski naukowiec
@pl
ricercatore polacco
@it
name
Zenon Czuba
@ast
Zenon Czuba
@ca
Zenon Czuba
@cs
Zenon Czuba
@de
Zenon Czuba
@en
Zenon Czuba
@es
Zenon Czuba
@fr
Zenon Czuba
@ga
Zenon Czuba
@gl
Zenon Czuba
@hr
type
label
Zenon Czuba
@ast
Zenon Czuba
@ca
Zenon Czuba
@cs
Zenon Czuba
@de
Zenon Czuba
@en
Zenon Czuba
@es
Zenon Czuba
@fr
Zenon Czuba
@ga
Zenon Czuba
@gl
Zenon Czuba
@hr
altLabel
Zenon P Czuba
@en
prefLabel
Zenon Czuba
@ast
Zenon Czuba
@ca
Zenon Czuba
@cs
Zenon Czuba
@de
Zenon Czuba
@en
Zenon Czuba
@es
Zenon Czuba
@fr
Zenon Czuba
@ga
Zenon Czuba
@gl
Zenon Czuba
@hr
P1412
P1559
Zenon Czuba
@pl
P21
P27
P31
P496
0000-0001-8216-4495